Article ID Journal Published Year Pages File Type
5702626 Urologic Oncology: Seminars and Original Investigations 2017 10 Pages PDF
Abstract
A beneficial oncologic response is observed in approximately half of the patients undergoing CN. Absence of radiographic progression at 3 months is an important marker for OS and STFS. Therefore, systemic treatment might be postponed in selected patients.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies
Authors
, , , , , , , , , , , , , , , , , , , ,